Basic concepts of molecular pathology

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 10, 2008, Pages 1551-1556

  Allen, Timothy Craig ^a   Cagle, Philip T ^b   Popper, Helmut H ^c  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; MESSENGER RNA; NUCLEIC ACID; NUCLEOTIDE DERIVATIVE; RNA; TRANSFER RNA;

CANCER GROWTH; CELL CYCLE; CELL STRUCTURE; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL SOCIETY; PLEURA CANCER; PROTEIN DEGRADATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TUMOR GENE; GENE EXPRESSION REGULATION; GENETICS; LUNG DISEASE; LUNG TUMOR; MOLECULAR BIOLOGY; PATHOLOGY; PROGNOSIS; REVIEW;

GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MOLECULAR BIOLOGY; PROGNOSIS;

EID: 54449101142     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (112)

1. Epstein RJ, ed. Human Molecular Biology: An Introduction to the Molecular Basis of Health and Disease. Cambridge, England: Cambridge University Press; 2003.
2. Coleman WB, Tsongalis GJ, eds. The Molecular Basis of Human Cancer. Totowa, NJ: Humana Press; 2002.
3. Watson JD, Baker TA, Bell SP, Gann A, Levine M, Losick R, eds. Molecular Biology of the Gene. 5th ed. Menlo Park, Calif: Benjamin Cummings; 2003.
4. Cooper GM, Hausman RE, eds. The Cell: A Molecular Approach. 3rd ed. Washington, DC: ASM Press/Sunderland, Mass: Sinauer Associates; 2004.
5. Farkas DH, ed. DNA From A to Z. Washington, DC: AACC Press; 2004.
6. Killeen AA, ed. Principles of Molecular Pathology. Totowa, NJ: Humana Press; 2004.
7. Haglund K, Dikic I. Ubiquitylation and cell signaling. EMBO J. 2005;24:3353-3359.
8. Thomas MC, Chiang CM. The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol. 2006;41:105-178.
9. Zaidi SK, Young DW, Choi JY, et al. The dynamic organization of generegulatory machinery in nuclear microenvironments. EMBO Rep. 2005;6:128-133.
10. Maston GA, Evans SK, Green MR. Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet. 2006;22:29-59.
11. Wang JC. Finding primary targets of transcriptional regulators. Cell Cycle. 2005;4:356-358.
12. Barrera LO, Ren B. The transcriptional regulatory code of eukaryotic cells: insights from genome-wide analysis of chromatin organization and transcription factor binding. Curr Opin Cell Biol. 2006;18:291-298.
13. Dillon N. Gene regulation and large-scale chromatin organization in the nucleus. Chromosome Res. 2006;14:117-126.
14. Scannell DR, Wolfe K. Rewiring the transcriptional regulatory circuits of cells. Genome Biol. 2004;5:206.
15. Villard J. Transcription regulation and human diseases. Swiss Med Wkly. 2004;134:571-579.
16. Brown LA, Huntsman D. Fluorescent in situ hybridization on tissue microarrays: challenges and solutions. J Mol Histol. 2007;38:151-157.
17. Halling KC, Kipp BR. Fluorescence in situ hybridization in diagnostic cytology. Hum Pathol. 2007;38:1137-1144.
18. Theodosiou Z, Kasmpalidis IN, Livanos G, et al. Automated analysis of FISH and immunohistochemistry images: a review. Cytometry. 2007;71A:439-450.
19. Dave BJ, Sanger WG. Role of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalances. Semin Pediatr Neurol. 2007;14:2-6.
20. Krishnamurthy S. Applications of molecular techniques to fine-needle aspiration biopsy. Cancer (Cancer Cytopathol). 2007;111:106-122.
21. Bayani J, Squire JA. Application and interpretation of FISH in biomarker studies. Cancer Lett. 2007;249:97-109.
22. Tenover FC. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin Infect Dis. 2006;44:418-423.
23. Petersen BL, Sorensen MC, Pedersen S, et al. Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method. Appl Immunohistochem Mol Morphol. 2004;12:259-265.
24. Morrison LE, Ramakrishnan R, Ruffalo TM, et al. Labeling fluorescence in situ hybridization probes for genomic targets. In: Fan Y-S, ed. Molecular Cytogenetics: Protocols and Applications. Vol 204. Totowa, NJ: Humana Press; 2002:21-40.
25. Van Stedum S, King W. Basic FISH techniques and trouble-shooting. In: Fan Y-S, ed. Molecular Cytogenetics: Protocols and Applications. Vol 204. Totowa, NJ: Humana Press; 2002:51-63.
26. Lee C, Wevrick R, Risher RB, et al. Human centromeric DNAs. Hum Genet. 1997;100:291-304.
27. McNichol AM, Farquharson MA. In situ hybridization and its diagnostic applications in pathology. J Pathol. 1997;182:250-261.
28. Solovei I, Walter J, Cremer C, et al. FISH on three-dimensionally preserved nuclei. In: Beatty B, Mai S, Squire J, eds. FISH: A Practical Approach. Oxford, England: Oxford University Press; 2002:119-158.
29. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350-1354.
30. Raad I, Hanna H, Huaringa A, et al. Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL. Chest. 2002;121:1171-1176.
31. Nogee LM, Dunbar AE III, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med. 2001;344:573-579.
32. Lordan JL, Bucchieri F, Richter A, et al. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol. 2002;169:407-414.
33. Westra WH, Baas IO, Hruban RH, et al. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 1996;56:2224-2228.
34. Pulte D, Li E, Crawford BK, et al. Sentinel lymph node mapping and molecular staging in nonsmall cell lung carcinoma. Cancer. 2005;104:1453-1461.
35. Bremnes RM, Sirera R, Camps C. Circulating tumour derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer. 2005;49:1-12.
36. Pan Q, Pao W, Ladanyi M. Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. J Mol Diagn. 2005;7:396-403.
37. Bohlmeyer T, Le TN, Shroyer AL, et al. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol. 1998;18:265-269.
38. Bevan IS, Rapley R, Walker MR. Sequencing of PCR amplified DNA. PCR Methods Appl. 1992;1:222-228.
39. McPherson MJ, Møller SG. PCR. Oxford, England: BIOS Scientific Publications; 2000.
40. Lie YS, Petropoulos CJ. Advances in quantitative PCR technology: 5′ nuclease assays. Curr Opin Biotechnol. 1998;9:43-48.
41. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986-994.
42. Livak KJ, Flood SJ, Marmaro J, et al. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl. 1995;4:357-362.
43. Bretagne S, Costa JM. Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol. 2005;45:361-368.
44. D'Cunha J, Maddaus MA. The use of real-time polymerase chain reaction in thoracic malignancies. Thorac Surg Clin. 2006;16:345-352.
45. Lam KM, Oldenburg N, Khan MA, et al. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients. J Heart Lung Transplant. 1998;17:555-565.
46. Singhal S, Wiewrodt R, Malden LD, et al. Gene expression profiling of malignant mesothelioma. Clin Cancer Res. 2003;9:3080-3097.
47. Dagnon K, Pacary E, Commo F, et al. Expression of erythropoietin and erythropoietin receptor in non-small cell lung carcinomas. Clin Cancer Res. 2005;11:993-999.
48. Mori M, Mimori K, Inoue H, et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res. 1995;55:3417-3420.
49. Salerno CT, Frizelle S, Niehans GA, et al. Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase- polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol. 1998;16:2632-2640.
50. Brugger W, Buhrling HJ, Grunebach F, et al. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol. 1999;17:1535-1544.
51. D'Cunha J, Corfits AL, Herndon JE, et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer-preliminary results of Cancer and Leukemia Group B Trial 9761. J Thorac Cardiovasc Surg. 2002;123:484-491.
52. Ge MJ, Wu QC, Wang M, et al. Detection of disseminated lung cancer cells in regional lymph nodes by assay of CK 19 reverse transcriptase polymerase chain reaction and its clinical significance. J Cancer Res Clin Oncol. 2005;131:662-628.
53. Sekido Y, Fong KM, Minna JD. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim Biophys Acta. 1998;1378(1):F21-F59.
54. Fong KM, Sekido Y, Minna JD. Molecular pathogenesis of lung cancer. J Thorac Cardiovasc Surg. 1999;118:1136-1152.
55. Virmani AK, Fong KM, Kodagoda D, et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer. 1998;21:308-319.
56. Lindblad-Toh K, Tanenbaum DM, Daly MJ, et al. Loss-of heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol. 2000;18:1001-1005.
57. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. Genomewide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000;60:4894-4906.
58. Zienolddiny S, Ryberg D, Arab MO, Skaug V, Haugen A. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer. Br J Cancer. 2001;84:226-231.
59. Hirao T, Nelson HH, Ashok TD, et al. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Cancer Res. 2001;61:612-615.
60. Wiencke JK, Kelsey KT. Teen smoking, field cancerization, and a "critical period" hypothesis for lung cancer susceptibility. Environ Health Perspect. 2002;110:555-558.
61. Wiencke JK. DNA adduct burden and tobacco carcinogenesis. Oncogene. 2002;21:7376-7391.
62. Shiseki MT, Kohno J, Adachi J, et al. Comparative allelotype of early and advanced stage non-small cell lung carcinomas. Genes Chromosomes Cancer. 1996;17:71-77.
63. Tseng RC, Chang JW, Hsien FJ, et al. Genomewide loss of heterozygosity and its clinical associations in non small cell lung cancer. Int J Cancer. 2005;117:241-247.
64. Powell CA, Klares S, O'Connor G, Brody JS. Loss of heterozygosity in epithelial cells obtained by bronchial brushing: clinical utility in lung cancer. Clin Cancer Res. 1999;5:2025-2034.
65. Powell CA, Bueno R, Borczuk AC, et al. Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers. Lung Cancer. 2003;39(1):23-29.
66. Pan H, Califano J, Ponte JF, et al. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer. Cancer Res. 2005;65:1664-1669.
67. Samara K, Zervou M, Siafakas NM, Tzortzaki EG. Microsatellite DNA instability in benign lung diseases. Respir Med. 2006;100:202-211.
68. Paraskakis E, Sourvinos G, Passam F, et al. Microsatellite DNA instability and loss of heterozygosity in bronchial asthma. Eur Respir J. 2003;22:951-955.
69. Karatzanis AD, Samara KD, Tzortzaki E, et al. Microsatellite DNA instability in nasal cytology of COPD patients. Oncol Rep. 2007;17:661-665.
70. Anderson GP, Bozinovski S. Acquired somatic mutations in the molecular pathogenesis of COPD. Trends Pharmacol Sci. 2003;24(2):71-76.
71. Uematsu K, Yoshimura A, Gemma A, et al. Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis. Cancer Res. 2001;61:8527-8533.
72. Malbon CC. A-kinase anchoring proteins: trafficking in G-protein-coupled receptors and the proteins that regulate receptor biology. Curr Opin Drug Discov Devel. 2007;10:573-579.
73. Fantl WJ, Johnson DE, Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem. 1993;62:453-481.
74. van der Geer P, Hunter T, Lindberg RA. Receptor protein tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol. 1994;10:251-337.
75. Perona R. Cell signalling: growth factors and tyrosine kinase receptors. Clin Transl Oncol. 2006;8:77-82.
76. Li E, Hristova K. Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies. Biochemistry. 2006;45:6241-6251.
77. Gavi S, Shumay E, Wang HY, Malbon CC. G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation. Trends Endocrinol Metab. 2006;17:48-54.
78. Tolwinski NS, Wieschaus E. Rethinking WNT signaling. Trends Genet. 2004;20:177-181.
79. Bejsovec A. Wnt pathway activation: new relations and locations. Cell. 2005;120:11-14.
80. Malbon CC. Frizzleds: new members of the superfamily of G-protein-coupled receptors. Front Biosci. 2004;9:1048-1058.
81. Takada R, Hijikata H, Kondoh H, Takada S. Analysis of combinatorial effects of Wnts and Frizzleds on betacatenin/armadillo stabilization and Dishevelled 77 phosphorylation. Genes Cells. 2005;10:919-928.
82. Tian Q. Proteomic exploration of the Wnt/beta-catenin pathway. Curr Opin Mol Ther. 2006;8:191-197.
83. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res. 2006;7:15.
84. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483-1487.
85. Vermeulen L, Vanden Berghe W, Haegeman G. Regulation of NF-kappaB transcriptional activity. Cancer Treat Res. 2006;130:89-102.
86. Wennerberg K, Rossman KL, Der CJ. The Ras superfamily at a glance. J Cell Sci. 2005;118(pt 5):843-846.
87. Park SH. Fine tuning and cross-talking of TGF-beta signal by inhibitory Smads. J Biochem Mol Biol. 2005;38:9-16.
88. Campbell KJ, Perkins ND. Regulation of NF-kappaB function. Biochem Soc Symp. 2006;73:165-180.
89. Massague J, Gomis RR. The logic of TGFbeta signaling. FEBS Lett. 2006;580:2811-2820.
90. Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol. 2006;24:771-800.
91. Sun XF, Zhang H. NFKB and NFKB1 polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol. 2007;22:1387-1398.
92. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev. 2005;19:2783-2810.
93. Mitin N, Rossman KL, Der CJ. Signaling interplay in Ras superfamily function. Curr Biol. 2005;15:R563-574.
94. Williams RS, Bernstein N, Lee MS, et al. Structural basis for phosphorylation-dependent signaling in the DNA damage response. Biochem Cell Biol. 2005;83:721-727.
95. Dianov GL, Sleeth KM, Dianova II, Allinson SL. Repair of abasic sites in DNA. Mutat Res. 2003;531:157-163.
96. Tsuzuki T, Nakatsu Y, Nakabeppu Y. Significance of error-avoiding mechanisms for oxidative DNA damage in carcinogenesis. Cancer Sci. 2007;98:465-470.
97. Zhang Y, Zhou J, Lim CU. The role of NBS1 in DNA double strand break repair, telomere stability, and cell cycle checkpoint control. Cell Res. 2006;16:45-54.
98. O'Driscoll M, Jeggo PA. The role of double-strand break repair: insights from human genetics. Nat Rev Genet. 2006;7:45-54.
99. Drablos F, Feyzi E, Aas PA, et al. Alkylation damage in DNA and RNA: repair mechanisms and medical significance. DNA Repair (Amst). 2004;3:1389-1407.
100. Lavin MF, Birrell G, Chen P, et al. ATM signaling and genomic stability in response to DNA damage. Mutat Res. 2005;569:123-132.
101. Lee JH, Paull TT. ATM activation by DNA double-strand breaks through the MRE11-RAD50-NBS1 complex. Science. 2005;308:551-554.
102. Abraham RT. PI 3-kinase related kinases: "big" players in stress-induced signaling pathways. DNA Repair (Amst). 2004;3:883-887.
103. Niida H, Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis. 2006;21:3-9.
104. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet. 2002;36:617-656.
105. Branzei D, Foiani M. The DNA damage response during DNA replication. Curr Opin Cell Biol. 2005;17:568-575.
106. Stark GR, Taylor WR. Analyzing the G2/M checkpoint. Methods Mol Biol. 2004;280:51-82.
107. Boonstra J. Progression through the G1-phase of the ongoing cell cycle. J Cell Biochem. 2003;90:244-252.
108. Ortega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta. 2002;1602:73-87.
109. Del Sal G, Murphy M, Ruaro E, et al. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene. 1996;12:177-185.
110. Chen CY, Oliner JD, Zhan Q, et al. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA. 1994;91:2684-2688.
111. Foulkes WD, Flanders TY, Pollock PM, Hayward NK. The CDKN2A (p16) gene and human cancer. Mol Med. 1997;3:5-20.
112. Huschtscha LI, Reddel RR. p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis. 1999;20:921-926.